Related Experiment Video
Updated: Feb 4, 2026

A Colorimetric Assay of Citrate Synthase Activity in Drosophila Melanogaster
Published on: January 16, 2020
2-Hydroxy-oleic acid does not activate sphingomyelin synthase activity
Bin Lou1, Qi Liu2, Jiahui Hou2
1From the School of Pharmacy, Fudan University, Shanghai 201203, China,.
Abstract:
2-Hydroxy-oleic acid (2OHOA) is a potent anticancer drug that induces cancer cell cycle arrest and apoptosis. Previous studies have suggested that 2OHOA's anticancer effect is mediated by SMS activation in cancer cells, including A549 and U118 cells. To confirm this phenomenon, in this study, we treated both A549 and U118 cells with 2OHOA and measured SMS activity. To our surprise, we found neither 2OHOA-mediated SMS activation nor sphingomyelin accumulation in the cells. However, we noted that 2OHOA significantly reduces phosphatidylcholine in these cells. We also did not observe 2OHOA-mediated SMS activation in mouse tissue homogenates. Importantly, 2OHOA inhibited rather than activated recombinant SMS1 (rSMS1) and rSMS2 in a dose-dependent fashion. Intra-gastric treatment of C57BL/6J mice with 2OHOA for 10 days had no effects on liver and small intestine SMS activities and plasma sphingomyelin levels. The treatment inhibited lysophosphatidylcholine acyltransferase (LPCAT) activity, consistent with the aforementioned reduction in plasma phosphatidylcholine. Because total cellular phosphatidylcholine is used as a predictive biomarker for monitoring tumor responses, the previously reported 2OHOA-mediated cancer suppression could be related to this phosphatidylcholine reduction, which may influence cell membrane structure and properties. We conclude that 2OHOA is not a SMS activator and that its anticancer property may be related to an effect on phosphatidylcholine metabolism.
Insights
2-Hydroxy-oleic acid (2OHOA) does not activate SMS enzymes as previously thought. Its anticancer effects may stem from reducing phosphatidylcholine levels, impacting cell membranes.
Area of Science:
- Biochemistry
- Cancer Biology
- Pharmacology
Background:
- 2-Hydroxy-oleic acid (2OHOA) is recognized for its anticancer properties, inducing apoptosis and cell cycle arrest.
- Prior research suggested its mechanism involved sphingomyelin synthase (SMS) activation in cancer cells.
Purpose of the Study:
- To investigate the proposed role of SMS activation in 2OHOA's anticancer effects.
- To examine the impact of 2OHOA on sphingomyelin and phosphatidylcholine metabolism in cancer cells and in vivo.
Main Methods:
- Treatment of A549 and U118 cancer cells with 2OHOA.
- Measurement of SMS activity, sphingomyelin, and phosphatidylcholine levels.
- Inhibition assays with recombinant SMS1 (rSMS1) and SMS2 (rSMS2).
- In vivo studies involving oral administration of 2OHOA to C57BL/6J mice, assessing SMS activity, sphingomyelin, and lysophosphatidylcholine acyltransferase (LPCAT) activity.
Main Results:
- 2OHOA did not activate SMS or increase sphingomyelin in treated cells or mouse tissues.
- A significant reduction in phosphatidylcholine was observed in cancer cells treated with 2OHOA.
- 2OHOA demonstrated dose-dependent inhibition of rSMS1 and rSMS2.
- In vivo, 2OHOA did not affect liver/intestinal SMS activity or plasma sphingomyelin but inhibited LPCAT activity.
Conclusions:
- 2OHOA is not an SMS activator; its anticancer effects are likely linked to phosphatidylcholine metabolism disruption.
- The reduction in phosphatidylcholine may alter cell membrane properties, contributing to observed anticancer activity.
- This finding reframes the understanding of 2OHOA's mechanism of action in cancer therapy.
Related Concept Videos
tRNA Activation
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These...
Acid–Base Equilibria: Activity-Based Definition of pH
In solutions of very low ionic strength—for example, pure water—the...
Co-activators and Co-repressors
Activation Energy
Prokaryotic Transcriptional Activators and Repressors
Transcription of prokaryotic...

